I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| microglial cell | 4 studies | 20% ± 5% | |
| macrophage | 3 studies | 18% ± 3% | |
| oligodendrocyte | 3 studies | 20% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| microglial cell | 4 studies | 20% ± 5% | |
| macrophage | 3 studies | 18% ± 3% | |
| oligodendrocyte | 3 studies | 20% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 26% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 3460.81 | 653 / 653 | 100% | 13.86 | 604 / 605 |
| ovary | 100% | 3178.14 | 180 / 180 | 100% | 20.51 | 429 / 430 |
| adrenal gland | 100% | 5889.62 | 258 / 258 | 100% | 20.85 | 229 / 230 |
| skin | 100% | 1900.81 | 1801 / 1809 | 100% | 28.26 | 472 / 472 |
| brain | 99% | 2095.38 | 2623 / 2642 | 100% | 20.86 | 702 / 705 |
| kidney | 100% | 2539.39 | 89 / 89 | 99% | 11.94 | 888 / 901 |
| esophagus | 100% | 2261.43 | 1439 / 1445 | 99% | 15.14 | 181 / 183 |
| breast | 100% | 2750.57 | 459 / 459 | 98% | 11.64 | 1100 / 1118 |
| lung | 100% | 3705.20 | 577 / 578 | 97% | 12.83 | 1125 / 1155 |
| bladder | 100% | 2663.71 | 21 / 21 | 97% | 12.43 | 487 / 504 |
| pancreas | 98% | 1013.39 | 321 / 328 | 98% | 13.82 | 174 / 178 |
| uterus | 100% | 3081.42 | 170 / 170 | 94% | 13.31 | 430 / 459 |
| stomach | 100% | 1624.29 | 359 / 359 | 93% | 9.23 | 266 / 286 |
| prostate | 100% | 3632.35 | 245 / 245 | 87% | 6.28 | 437 / 502 |
| intestine | 97% | 2123.34 | 939 / 966 | 90% | 7.08 | 473 / 527 |
| liver | 98% | 1267.98 | 222 / 226 | 73% | 5.87 | 295 / 406 |
| adipose | 100% | 3072.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 27.49 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 10.96 | 29 / 29 |
| spleen | 100% | 2934.96 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 9.16 | 1 / 1 |
| blood vessel | 100% | 2849.42 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 100% | 2976.54 | 860 / 861 | 0% | 0 | 0 / 0 |
| muscle | 99% | 1324.39 | 796 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 2064.32 | 897 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 8.78 | 43 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007019 | Biological process | microtubule depolymerization |
| GO_0001578 | Biological process | microtubule bundle formation |
| GO_0005813 | Cellular component | centrosome |
| GO_0035371 | Cellular component | microtubule plus-end |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | NCKAP5L |
| Protein name | NCK associated protein 5 like Nck-associated protein 5-like (NCKAP5-like) (Centrosomal protein of 169 kDa) (Cep169) |
| Synonyms | CEP169 FP1193 KIAA1602 |
| Description | FUNCTION: Regulates microtubule organization and stabilization. Promotes microtubule growth and bundling formation and stabilizes microtubules by increasing intense acetylation of microtubules . Both tubulin-binding and homodimer formation are required for NCKAP5L-mediated microtubule bundle formation . . |
| Accessions | ENST00000335999.7 [Q9HCH0-1] H7C1V4 Q9HCH0 ENST00000433948.5 |
